A 3-month-old infant with neuroblastoma complicated by progressive depletion of coagulation factors and a microangiopathic haemolytic anaemia is described. Specific anti-tumour therapy corrected the haemorrhagic defect on 2 occasions, but did not affect tumour bulk significantly, although a fall in urinary vanillyl-mandelic acid was seen. The rarity of this association and the possible underlying mechanisms are discussed.
Introduction
Neuroblastoma is a common solid tumour of childhood, exceeded only in frequency by brain tumours. The varied clinical course is well known with often spontaneous regression of localized or disseminated tumour in young infants, with or without therapy. Prognosis is often best in infants less than one year of age and for the child with 4S disease (Evans, d'Angio and Randolph, 1971) , namely wide dissemination to liver, bone marrow and/or skin but no skeletal involvement. However, despite a large literature on this neoplasm there have only been 2 recorded cases of disseminated intravascular coagulation (DIC) occurring in conjunction with this tumour (McMillan, Gaundry and Holemans, 1968; Faxelius et al., 1975) . In both instances the infants were very young (3 days and 10 weeks) both had Stage 4S disease and both had the primary lesion in the right adrenal with metastases to the liver, marrow and the other adrenal. Ltd; Didcot, U.K.). Factor V was assayed by the method of Kapeller (1955) as described by Giddings, Shearn and Bloom (1975) , factor VII as described by Garner and Conning (1970) , factor VIII by the method of Pool and Robinson (1959) and factor XI by the method of Giddings (1971) . Other quantitative assays were performed by one-stage techniques using substrate plasma samples obtained from patients congenitally deficient in the respective factor (Denson, 1966) . The greatest reduction was seen in factors VII, IX, X, II and I, which changed from 64-88 %, 36-120%, 36-80%, 21-38%, 1/4-1/16 respectively, whereas factors V and VIII were 50 and 61 % respectively (Table 2 ). Unfortunately none of (Al-Mondhiry, 1975) . In some cases the coagulopathy may be asymptomatic and only detected on investigation (Al-Mondhiry, 1975; Peck and Reiquam, 1973 (Girolani, 1967 (Dargeon, 1962; de Lorimier, Bragg and Linden, 1969; d'Angio, Evans and Koop, 1971; Schwartz et al., 1974) and the higher incidence of asymptomatic neuroblastoma in situ in infants less than 3 months of age well documented (Beckwith and Perrin, 1963) . Spontaneous regression of widespread metastatic disease is well known and more likely to occur in very young infants (Everson and Cole, 1966 Schwartz et al., 1974; Bond, 1976) . In spite of the better clinical course run by children with 4S disease, it is interesting that the 6 patients recorded by Pepper (1901) were aged 1-8 weeks at diagnosis, all had massive hepatic metastases (from bilateral adrenal tumours in 2, right adrenal in 2, left adrenal in one, other primary not found), and all died within a few weeks of diagnosis. All had extensively metastasised to the liver exclusively and so were stage 4S cases. Post-mortem findings showed massive haemorrhagic tumour in the liver. There was no reference to a haemorrhagic tendency before death.
It is tempting to speculate that this very vascular tumour with vascular hepatic metastases invading the portal sinusoids of the liver, activates the coagulation system by thromboplastic material released from tumour tissues and/or destruction of the endothelium of the sinusoids by tumour invasion (Merskey et al., 1967; Peck and Reiquam, 1973; Sun et al., 1974; Al-Mondhiry, 1975) . Perhaps the association of DIC in this tumour is not so rare as is suggested by the 3 cases reported, and that this may be present if looked for using the appropriate tests. Alternatively, this complication may be related to the predominant site of the metastases and the age of the patient. However, the clinical vagaries of this tumour are well known and perhaps an abnormality of the clotting mechanism may be present in only some of them.
